Oppenheimer & CO Inc Tarsus Pharmaceuticals, Inc. Transaction History
Oppenheimer & CO Inc
- $6.52 Billion
- Q4 2024
A detailed history of Oppenheimer & CO Inc transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 4,100 shares of TARS stock, worth $212,216. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,100Holding current value
$212,216% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding TARS
# of Institutions
178Shares Held
43.5MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$177 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$169 Million0.0% of portfolio
-
Jennison Associates LLC2.5MShares$129 Million0.09% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$126 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$117 Million6.32% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.38B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...